CureVac Statistics

Total Valuation

CureVac has a market cap or net worth of GBP 721.24 million. The enterprise value is 579.02 million.

Market Cap	721.24M
Enterprise Value	579.02M

Important Dates

The next estimated earnings date is Friday, April 25, 2025.

Earnings Date	Apr 25, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+9.65%
Shares Change (QoQ)	+0.01%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	123.54M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	2.43
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-2.45
EV / Sales	10.11
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-2.11

Financial Position

The company has a current ratio of 2.29, with a Debt / Equity ratio of 0.10.

Current Ratio	2.29
Quick Ratio	2.19
Debt / Equity	0.10
Debt / EBITDA	n/a
Debt / FCF	-0.12
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -54.30% and return on invested capital (ROIC) is -32.31%.

Return on Equity (ROE)	-54.30%
Return on Assets (ROA)	-24.52%
Return on Capital (ROIC)	-32.31%
Revenue Per Employee	51,415
Profits Per Employee	-217,365
Employee Count	1,172
Asset Turnover	0.09
Inventory Turnover	13.43

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +13.86% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+13.86%
50-Day Moving Average	3.26
200-Day Moving Average	3.22
Relative Strength Index (RSI)	55.48
Average Volume (20 Days)	29,310

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	5.01

Income Statement

In the last 12 months, CureVac had revenue of GBP 55.84 million and -236.06 million in losses. Loss per share was -1.05.

Revenue	55.84M
Gross Profit	-73.15M
Operating Income	-242.17M
Pretax Income	-234.25M
Net Income	-236.06M
EBITDA	-229.20M
EBIT	-242.17M
Loss Per Share	-1.05

Full Income Statement

Balance Sheet

The company has 171.70 million in cash and 33.09 million in debt, giving a net cash position of 138.60 million.

Cash & Cash Equivalents	171.70M
Total Debt	33.09M
Net Cash	138.60M
Net Cash Per Share	n/a
Equity (Book Value)	319.23M
Book Value Per Share	1.42
Working Capital	120.03M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -245.74 million and capital expenditures -28.47 million, giving a free cash flow of -274.22 million.

Operating Cash Flow	-245.74M
Capital Expenditures	-28.47M
Free Cash Flow	-274.22M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	-131.00%
Operating Margin	-433.71%
Pretax Margin	-419.52%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CureVac does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-9.65%
Shareholder Yield	-9.65%
Earnings Yield	-32.73%
FCF Yield	-38.02%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

CureVac has an Altman Z-Score of -1.94. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-1.94
Piotroski F-Score	n/a